LIVIVO - The Search Portal for Life Sciences

zur deutschen Oberfläche wechseln
Advanced search

Search results

Result 1 - 10 of total 18

Search options

  1. Article ; Online: Clear-cell renal cell carcinoma single thyroid metastasis: A single-center retrospective analysis and review of the literature.

    Ricci, Isabella / Barillaro, Francesco / Conti, Enrico / Intersimone, Donatella / Dessanti, Paolo / Aschele, Carlo

    Archivio italiano di urologia, andrologia : organo ufficiale [di] Societa italiana di ecografia urologica e nefrologica

    2021  Volume 93, Issue 1, Page(s) 68–70

    Abstract: Renal cell carcinoma (RCC) is known to cause metastasis to unusual sites, which can be both synchronous or metachronous. Thyroid gland is a rare site for metastasis. However, RCC is the most common primary neoplasm to metastasize to the Thyroid gland. ... ...

    Abstract Renal cell carcinoma (RCC) is known to cause metastasis to unusual sites, which can be both synchronous or metachronous. Thyroid gland is a rare site for metastasis. However, RCC is the most common primary neoplasm to metastasize to the Thyroid gland. Report of three cases and review of the literature.
    MeSH term(s) Aged ; Carcinoma, Renal Cell/secondary ; Female ; Humans ; Kidney Neoplasms/pathology ; Male ; Middle Aged ; Retrospective Studies ; Thyroid Neoplasms/secondary
    Language English
    Publishing date 2021-03-19
    Publishing country Italy
    Document type Case Reports ; Journal Article ; Review
    ZDB-ID 1153526-x
    ISSN 2282-4197 ; 1120-8538 ; 1124-3562
    ISSN (online) 2282-4197
    ISSN 1120-8538 ; 1124-3562
    DOI 10.4081/aiua.2021.1.68
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  2. Article ; Online: Assessment of interferon-γ in pleural fluid as a prognostic factor of survival in malignant pleural mesothelioma.

    Dozin, Beatrice / Carbotti, Grazia / Roncella, Silvio / Ferro, Paola / Dessanti, Paolo / Canessa, Pier Aldo / Ferrini, Silvano / Fabbi, Marina

    Cancer immunology, immunotherapy : CII

    2021  Volume 70, Issue 11, Page(s) 3349–3355

    Abstract: Backgound: Literature reports suggest that the host immune system may control Malignant Pleural Mesothelioma (MPM) growth, although its activity is limited by regulatory mechanisms. In this retrospective study, we analyzed the levels of pro-inflammatory ...

    Abstract Backgound: Literature reports suggest that the host immune system may control Malignant Pleural Mesothelioma (MPM) growth, although its activity is limited by regulatory mechanisms. In this retrospective study, we analyzed the levels of pro-inflammatory (IL-1, IL-6, TNF), immune-regulatory (IL-10) and Th1/CTL-related cytokines (IL-12p70, IFN-γ) in the pleural exudate and their relationship with overall survival (OS) in MPM.
    Methods: Cytokines were quantified by multiplexed immunoassay. Concentrations were dichotomized with respect to the median value. Correlation between cytokine level and OS was assessed using univariate (Kaplan-Meier curves) and multivariate (Cox regression) analyses.
    Results: Regarding outcome, tumor histology, therapies undergone and IFN-γ were independent prognostic factors of OS in a 72 MPM training cohort. Notably, high concentrations of IFN-γ halved death probability (HR of high vs low IFN-γ concentration = 0.491, 95%CI 0.3-0.8, p = 0.007). Also in patients with epithelioid histology and those receiving at least one line of therapy, high IFN-γ level was an independent factor predictive of OS (HR of high vs low IFN-γ concentration were 0.497, p = 0.007 and 0.324, p = 0.006, respectively). However, these data were not confirmed in a 77 MPM validation cohort, possibly due to the low IFN-γ levels encountered in this population, and the heterogeneous distribution of disease stages between the training and the validation cohorts. None of the other cytokines showed any effect on survival.
    Conclusions: High level of IFN-γ in pleural effusion may be associated with better survival in MPM patients and potentially serve as a prognostic biomarker. Larger prospective studies are needed to ascertain this hypothesis.
    MeSH term(s) Adult ; Aged ; Cytokines/analysis ; Female ; Humans ; Interferon-gamma/metabolism ; Male ; Mesothelioma, Malignant/immunology ; Mesothelioma, Malignant/mortality ; Mesothelioma, Malignant/pathology ; Middle Aged ; Pleural Effusion, Malignant/immunology ; Pleural Effusion, Malignant/metabolism ; Pleural Neoplasms/immunology ; Pleural Neoplasms/mortality ; Pleural Neoplasms/pathology ; Prognosis ; Retrospective Studies
    Chemical Substances Cytokines ; Interferon-gamma (82115-62-6)
    Language English
    Publishing date 2021-05-18
    Publishing country Germany
    Document type Journal Article
    ZDB-ID 195342-4
    ISSN 1432-0851 ; 0340-7004
    ISSN (online) 1432-0851
    ISSN 0340-7004
    DOI 10.1007/s00262-021-02965-w
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  3. Article ; Online: Solitary Fibrous Tumor of the Deep Parotid Gland.

    Romano, Nicola / Ferrari, Alice / Moroni, Michele / Dessanti, Paolo / Bardine, Alex / D'Amato, Massimo / Stefanini, Teseo

    Ear, nose, & throat journal

    2020  Volume 101, Issue 7, Page(s) NP291–NP293

    MeSH term(s) Humans ; Parotid Gland/diagnostic imaging ; Parotid Gland/pathology ; Parotid Neoplasms/diagnostic imaging ; Parotid Neoplasms/pathology ; Parotid Neoplasms/surgery ; Solitary Fibrous Tumors/diagnostic imaging ; Solitary Fibrous Tumors/surgery
    Language English
    Publishing date 2020-10-14
    Publishing country United States
    Document type Journal Article
    ZDB-ID 750153-5
    ISSN 1942-7522 ; 0145-5613
    ISSN (online) 1942-7522
    ISSN 0145-5613
    DOI 10.1177/0145561320966068
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  4. Article: Primary melanoma of the bladder: Case report and review of the literature.

    Barillaro, Francesco / Camilli, Marco / Dessanti, Paolo / Gorji, Nader / Chiesa, Fabio / Villa, Alessandro / Pastorino, Alessandro / Aschele, Carlo / Conti, Enrico

    Archivio italiano di urologia, andrologia : organo ufficiale [di] Societa italiana di ecografia urologica e nefrologica

    2018  Volume 90, Issue 3, Page(s) 224–226

    Abstract: Skin melanoma represents one of the most common and lethal solid tumor. It usually develops on the skin but it can occur in any tissues with melanine- containing-cells (extracutaneous malignant melanoma). Only 4-5% of malignant melanomas originate in ... ...

    Abstract Skin melanoma represents one of the most common and lethal solid tumor. It usually develops on the skin but it can occur in any tissues with melanine- containing-cells (extracutaneous malignant melanoma). Only 4-5% of malignant melanomas originate in extracutaneous tissues, and they have an extremely lethal behavior (1). These non-skin malignant melanomas are rare but extremely aggressive. Primary melanoma of the genitourinary tract accounts for less than 0.2% of all melanomas. To date only 28 cases of primary bladder melanoma (PMM) are described. We report a rare case of PMM of the bladder in a 72 years old man treated with radical cystectomy and immunotherapy with Nivolumab.
    MeSH term(s) Aged ; Antineoplastic Agents, Immunological/administration & dosage ; Combined Modality Therapy ; Cystectomy/methods ; Humans ; Immunotherapy/methods ; Male ; Melanoma/diagnosis ; Melanoma/pathology ; Melanoma/therapy ; Nivolumab/administration & dosage ; Urinary Bladder Neoplasms/diagnosis ; Urinary Bladder Neoplasms/pathology ; Urinary Bladder Neoplasms/therapy
    Chemical Substances Antineoplastic Agents, Immunological ; Nivolumab (31YO63LBSN)
    Language English
    Publishing date 2018-09-30
    Publishing country Italy
    Document type Case Reports ; Journal Article ; Review
    ZDB-ID 1153526-x
    ISSN 2282-4197 ; 1124-3562 ; 1120-8538
    ISSN (online) 2282-4197
    ISSN 1124-3562 ; 1120-8538
    DOI 10.4081/aiua.2018.3.224
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  5. Article: Potential role of serum mesothelin in predicting survival of patients with malignant pleural mesothelioma.

    Fontana, Vincenzo / Pistillo, Maria Pia / Vigani, Antonella / Canessa, Pier Aldo / Berisso, Giovanni / Giannoni, Ugo / Ferro, Paola / Franceschini, Maria Cristiana / Carosio, Roberta / Tonarelli, Marika / Dessanti, Paolo / Roncella, Silvio

    Oncology letters

    2020  Volume 21, Issue 2, Page(s) 128

    Abstract: Malignant pleural mesothelioma (MPM) is an aggressive tumor with poor survival rates. Therefore, it is essential to have effective biological markers predicting the course of the disease and prognosis. The aim of the present study was to highlight the ... ...

    Abstract Malignant pleural mesothelioma (MPM) is an aggressive tumor with poor survival rates. Therefore, it is essential to have effective biological markers predicting the course of the disease and prognosis. The aim of the present study was to highlight the prognostic significance of serum soluble mesothelin-related protein (Se-SMRP) in patients with MPM at diagnosis. Se-SMRP was determined in 60 patients using an ELISA commercial kit. Se-SMRP levels were subdivided into three tertile-based categories and in each category overall survival (OS) indexes were determined using the Kaplan-Meier and Cox regression analyses. The association between Se-SMRP levels and OS was also assessed by restricted cubic spline (RCS) analysis. No notable differences in the Kaplan-Meier probabilities were identified across the Se-SMRP categories (<0.66 nM, 0.66-1.46 nM, >1.46 nM) although an upward trend in death rate ratios (RR) was pointed out by comparing the higher (RR=1.95) and intermediate (RR=1.86) categories with the lower category (RR=1.00). In addition, such an increasing tendency, particularly when the biomarker exceeded 1.0 nM, was confirmed by an RCS function of Se-SMPR levels fitted to survival data using the Cox regression equation. The present study provided evidence in favor of a prognostic value of Se-SMRP in patients with MPM.
    Language English
    Publishing date 2020-12-18
    Publishing country Greece
    Document type Journal Article
    ZDB-ID 2573196-8
    ISSN 1792-1082 ; 1792-1074
    ISSN (online) 1792-1082
    ISSN 1792-1074
    DOI 10.3892/ol.2020.12389
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  6. Article ; Online: Characterization of soluble PD-L1 in pleural effusions of mesothelioma patients: potential implications in the immune response and prognosis.

    Carosio, Roberta / Fontana, Vincenzo / Mastracci, Luca / Ferro, Paola / Grillo, Federica / Banelli, Barbara / Canessa, Pier Aldo / Dessanti, Paolo / Vigani, Antonella / Morabito, Anna / Pfeffer, Ulrich / Poggi, Alessandro / Roncella, Silvio / Pistillo, Maria Pia

    Journal of cancer research and clinical oncology

    2020  Volume 147, Issue 2, Page(s) 459–468

    Abstract: Purpose: Programmed death-ligand 1 (PD-L1) protein plays a central role in the antitumor immune response, and appears to be a predictor of prognosis and efficacy for PD-L1 and programmed death 1 (PD-1) blockade therapy. The immunoregulatory role and ... ...

    Abstract Purpose: Programmed death-ligand 1 (PD-L1) protein plays a central role in the antitumor immune response, and appears to be a predictor of prognosis and efficacy for PD-L1 and programmed death 1 (PD-1) blockade therapy. The immunoregulatory role and prognostic impact of PD-L1 soluble form (sPD-L1) have been investigated in biological fluids of patients with different tumors. In malignant pleural mesothelioma (MPM), circulating sPD-L1 has been recently reported in patients' sera, but no data are available in pleural effusions (PE). In our study, we evaluated the baseline expression levels of sPD-L1 in PE from 84 MPM patients and correlated them with PD-L1-status in matched tumors and patients' overall survival (OS).
    Methods: sPD-L1 in PE was determined by ELISA and tumor PD-L1 by immunohistochemistry. Association of sPD-L1 with OS was estimated using the Cox regression model.
    Results: We observed that sPD-L1 was variably expressed in all the PE and tended to be higher (by 30%) in patients with PD-L1-positive tumors (cut-off ≥ 1% stained cells) as compared to patients with PD-L1-negative tumors (geometric mean ratio = 1.28, P value = 0.288). sPD-L1 levels were significantly higher than those of sPD-1 (P value = 0.001) regardless of the MPM histotypes and they were positively correlated (r = 0.50, P value < 0.001). Moreover, high PE sPD-L1 concentrations were associated with a trend towards increased OS (hazard ratio 0.79, 95% CL 0.62-1.01, P value = 0.062).
    Conclusions: Our study documents the presence of sPD-L1 in PE of MPM patients, and suggests its possible biological and prognostic role in MPM.
    MeSH term(s) Aged ; Aged, 80 and over ; B7-H1 Antigen/analysis ; B7-H1 Antigen/physiology ; Female ; Humans ; Immunohistochemistry ; Male ; Mesothelioma, Malignant/immunology ; Mesothelioma, Malignant/mortality ; Middle Aged ; Pleural Effusion/metabolism ; Prognosis ; Programmed Cell Death 1 Receptor/analysis ; Proportional Hazards Models
    Chemical Substances B7-H1 Antigen ; CD274 protein, human ; PDCD1 protein, human ; Programmed Cell Death 1 Receptor
    Language English
    Publishing date 2020-11-20
    Publishing country Germany
    Document type Journal Article
    ZDB-ID 134792-5
    ISSN 1432-1335 ; 0171-5216 ; 0084-5353 ; 0943-9382
    ISSN (online) 1432-1335
    ISSN 0171-5216 ; 0084-5353 ; 0943-9382
    DOI 10.1007/s00432-020-03457-7
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  7. Article ; Online: Determination of Mesothelin Levels in Pleural Effusion Does Not Help Predict Survival of Patients With Malignant Pleural Mesothelioma.

    Fontana, Vincenzo / Pistillo, Maria Pia / Vigani, Antonella / Canessa, Pier Aldo / Berisso, Giovanni / Giannoni, Ugo / Ferro, Paola / Franceschini, Maria Cristiana / Carosio, Roberta / Tonarelli, Marika / Rossi, Cristiana / Dessanti, Paolo / Roncella, Silvio

    Anticancer research

    2019  Volume 39, Issue 9, Page(s) 5219–5223

    Abstract: Aim: This study evaluated the prognostic value of soluble mesothelin-related protein (SMRP) levels in pleural effusions (PE) from patients with pleural mesothelioma (MPM).: Patients and methods: SMRP level in PE was tested using an enzyme-linked ... ...

    Abstract Aim: This study evaluated the prognostic value of soluble mesothelin-related protein (SMRP) levels in pleural effusions (PE) from patients with pleural mesothelioma (MPM).
    Patients and methods: SMRP level in PE was tested using an enzyme-linked immunosorbent assay (ELISA) in 109 patients with MPM at diagnosis before any treatment. The Kaplan-Meier method and the Cox regression were applied to compare overall survival probabilities across tertile categories of SMRP level.
    Results: No significant differences in Kaplan-Meier overall survival probabilities among the SMRP categories were found. A statistically non-significant trend for increased death rate ratio (RR) was computed (p=0.327) when the higher (>46.5 nM, RR=1.38) and intermediate (8.5-46.5 nM, RR=1.18) SMRP categories were compared to the lower category (<8.5 nM, RR=1.00). Cox regression modelling including a restricted cubic spline showed a moderately rising non-linear trend in death rate.
    Conclusion: The SMRP level in PE does not appear to have prognostic significance and its detection is not recommended in routine clinical management of patients with MPM.
    MeSH term(s) Aged ; Aged, 80 and over ; Antineoplastic Combined Chemotherapy Protocols/adverse effects ; Antineoplastic Combined Chemotherapy Protocols/therapeutic use ; Biomarkers, Tumor ; Female ; GPI-Linked Proteins/metabolism ; Humans ; Lung Neoplasms/complications ; Lung Neoplasms/diagnosis ; Lung Neoplasms/mortality ; Lung Neoplasms/therapy ; Male ; Mesothelioma/complications ; Mesothelioma/diagnosis ; Mesothelioma/mortality ; Mesothelioma/therapy ; Mesothelioma, Malignant ; Middle Aged ; Pleural Effusion, Malignant/diagnosis ; Pleural Effusion, Malignant/etiology ; Pleural Effusion, Malignant/metabolism ; Pleural Effusion, Malignant/therapy ; Pleural Neoplasms/complications ; Pleural Neoplasms/diagnosis ; Pleural Neoplasms/mortality ; Pleural Neoplasms/therapy ; Prognosis ; ROC Curve ; Treatment Outcome
    Chemical Substances Biomarkers, Tumor ; GPI-Linked Proteins ; mesothelin (J27WDC343N)
    Language English
    Publishing date 2019-09-13
    Publishing country Greece
    Document type Journal Article
    ZDB-ID 604549-2
    ISSN 1791-7530 ; 0250-7005
    ISSN (online) 1791-7530
    ISSN 0250-7005
    DOI 10.21873/anticanres.13719
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  8. Article ; Online: Comparison of the Diagnostic Performance of Fibulin-3 and Mesothelin in Patients with Pleural Effusions from Malignant Mesothelioma.

    Battolla, Enrico / Canessa, Pier Aldo / Ferro, Paola / Franceschini, Maria Cristiana / Fontana, Vincenzo / Dessanti, Paolo / Pinelli, Valentina / Morabito, Anna / Fedeli, Franco / Pistillo, Maria Pia / Roncella, Silvio

    Anticancer research

    2017  Volume 37, Issue 3, Page(s) 1387–1391

    Abstract: Background: In the literature, there exist conflicting data on the value of fibulin-3 (FBLN3) for the diagnosis of pleural effusion (PE) in malignant pleural mesothelioma (MPM). Therefore we compared the diagnostic performance of FBLN3 against that of ... ...

    Abstract Background: In the literature, there exist conflicting data on the value of fibulin-3 (FBLN3) for the diagnosis of pleural effusion (PE) in malignant pleural mesothelioma (MPM). Therefore we compared the diagnostic performance of FBLN3 against that of soluble mesothelin-related peptide (SMRP) in a cohort of Italian patients.
    Materials and methods: FBLN3 and SMRP were detected in PE from 33 patients with MPM, 64 with pleural benign lesions and 23 with non-MPM pleural metastases using a commercial enzyme-linked-immunosorbent(ELISA)-assay kit according to manufacturers' instructions.
    Results: Levels of FBLN3 were similar in PE from MPM and PE from other pathologies (geometric mean=68.1 vs. 66.2 ng/ml; p=0.872) in contrast to SMRP levels, which were significantly higher in PE from MPM (geometric mean=14.6 vs. 3.2 nM; p<0.001). Receiver operating characteristic analysis confirmed that SMRP showed a good performance (area under the curve=0.79, p<0.001), whereas FBLN3 was not able to discriminate MPM from other pathologies (area under the curve=0.44, p=0.838).
    Conclusion: FBLN3 detection in PE, in contrast to SMRP detection, is not useful as a biomarker for the diagnosis of PE from MPM.
    MeSH term(s) Aged ; Aged, 80 and over ; Biomarkers, Tumor/metabolism ; Cohort Studies ; Enzyme-Linked Immunosorbent Assay ; Extracellular Matrix Proteins/metabolism ; Female ; Gene Expression Regulation, Neoplastic ; Humans ; Italy ; Lung Neoplasms/metabolism ; Lung Neoplasms/pathology ; Male ; Mesothelioma/metabolism ; Mesothelioma/pathology ; Mesothelioma, Malignant ; Middle Aged ; Multidrug Resistance-Associated Proteins/metabolism ; Pleural Effusion, Malignant/metabolism ; Pleural Effusion, Malignant/pathology ; Pleural Neoplasms/metabolism ; Pleural Neoplasms/pathology ; ROC Curve
    Chemical Substances ABCC5 protein, human ; Biomarkers, Tumor ; EFEMP1 protein, human ; Extracellular Matrix Proteins ; Multidrug Resistance-Associated Proteins
    Language English
    Publishing date 2017-03-16
    Publishing country Greece
    Document type Comparative Study ; Journal Article
    ZDB-ID 604549-2
    ISSN 1791-7530 ; 0250-7005
    ISSN (online) 1791-7530
    ISSN 0250-7005
    DOI 10.21873/anticanres.11460
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  9. Article ; Online: Primary cardiac lymphoma presenting as sick sinus syndrome.

    Motto, Andrea / Ballo, Piercarlo / Zito, Domenico / Cadenotti, Luigi / Moroni, Michele / Dessanti, Paolo / Fedeli, Franco

    Journal of clinical oncology : official journal of the American Society of Clinical Oncology

    2008  Volume 26, Issue 36, Page(s) 6003–6005

    MeSH term(s) Aged ; Diagnosis, Differential ; Echocardiography ; Female ; Heart Neoplasms/diagnosis ; Humans ; Lymphoma, B-Cell/diagnosis ; Sick Sinus Syndrome/diagnosis ; Tomography, X-Ray Computed
    Language English
    Publishing date 2008-12-20
    Publishing country United States
    Document type Case Reports ; Journal Article
    ZDB-ID 604914-x
    ISSN 1527-7755 ; 0732-183X
    ISSN (online) 1527-7755
    ISSN 0732-183X
    DOI 10.1200/JCO.2008.19.4803
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  10. Article ; Online: Mesothelin in serum and pleural effusion in the diagnosis of malignant pleural mesothelioma with non-positive cytology.

    Franceschini, Maria Cristiana / Ferro, Paola / Canessa, Pier Aldo / Battolla, Enrico / Dessanti, Paolo / Valentino, Alessandro / Casolari, Laura / Fontana, Vincenzo / Pezzi, Riccardo / Fedeli, Franco / Pistillo, Maria Pia / Roncella, Silvio

    Anticancer research

    2014  Volume 34, Issue 12, Page(s) 7425–7429

    Abstract: Background/aim: Mesothelin (SMRP) is regarded as a biomarker of malignant pleural mesothelioma (MPM). Herein, we analyzed the contribution of SMRP detection in pleural effusion and in serum to the diagnosis of MPM with non-positive cytology.: ... ...

    Abstract Background/aim: Mesothelin (SMRP) is regarded as a biomarker of malignant pleural mesothelioma (MPM). Herein, we analyzed the contribution of SMRP detection in pleural effusion and in serum to the diagnosis of MPM with non-positive cytology.
    Materials and methods: The present study included 52 cases of MPM, 43 of pleural benign lesions and 25 of non-MPM pleural metastases. SMRP was measured by MesoMark ELISA (Cis-Bio International Gif/Yvette; France).
    Results: In non-positive cytology, effusion-SMRP showed higher diagnostic performance than serum-SMRP. We found 38 out of 52 (73.1%) cases of non-positive cytology MPM, out of which 27 (71.0%) were positive for effusion-SMRP (cut-off=12.70 nM) and 18 (47.4%) for serum-SMRP (cut-off=1.08 nM). When cytology, effusion- and serum-SMRP were used in combination, an overall sensitivity in detection of MPM of 78.9% was achieved. The same sensitivity was obtained by combining cytology with effusion-SMRP alone, whereas the combination of serum-SMRP with cytology led to a sensitivity of 61.5%.
    Conclusion: Detection of both effusion- and serum-SMRP can contribute to improve the diagnosis of MPM with non-positive cytology. However, the analysis of SMRP in effusion makes it unnecessary to test SMRP in the serum.
    MeSH term(s) Aged ; Aged, 80 and over ; Asbestosis/blood ; Biomarkers, Tumor/blood ; Cytodiagnosis ; Female ; GPI-Linked Proteins/blood ; Humans ; Lung Neoplasms/blood ; Lung Neoplasms/diagnosis ; Lung Neoplasms/pathology ; Male ; Mesothelioma/blood ; Mesothelioma/diagnosis ; Mesothelioma/pathology ; Mesothelioma, Malignant ; Middle Aged ; Neoplasm Metastasis ; Pleural Effusion/pathology ; Pleural Neoplasms/blood ; Pleural Neoplasms/diagnosis ; Pleural Neoplasms/pathology
    Chemical Substances Biomarkers, Tumor ; GPI-Linked Proteins ; mesothelin (J27WDC343N)
    Language English
    Publishing date 2014-12-12
    Publishing country Greece
    Document type Journal Article ; Research Support, Non-U.S. Gov't
    ZDB-ID 604549-2
    ISSN 1791-7530 ; 0250-7005
    ISSN (online) 1791-7530
    ISSN 0250-7005
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

To top